The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis
Abstract
Xpert MTB/RIF (Xpert) is recommended for human immunodeficiency virus (HIV)-associated pulmonary tuberculosis but not extrapulmonary tuberculosis. We assessed the performance of Xpert for HIV-associated lymph node tuberculosis (LNTB), the most common type of extrapulmonary tuberculosis. Among HIV-infected adults suspected of LNTB presenting for fine needle aspirate (FNA) at a South African hospital, we assessed the diagnostic accuracy of Xpert using either FNA culture or a composite of microscopy, culture, and cytology as the reference standard, and evaluated the impact of different diagnostics on patient management. Among 344 adults with valid FNA culture and Xpert results, 84 (24 %) were positive on microscopy, 149 (43 %) on culture, 152 (53 %) on Xpert, and 181 (57 %) had a cytology result suggestive of tuberculosis. Using liquid culture as the reference standard, the specificity of a single Xpert was suboptimal (88.2 %) but the sensitivity was high [93.3 %, 95 % confidence interval (CI) 87.6-96.6] and increased with decreasing CD4 count (from 87.0 % for CD4 >250 to 98.6 % for CD4 <100 cells/mm(3)). Using a composite reference standard reduced the sensitivity to 79.2 % but increased the specificity to 98.6 %. All Xpert-positive patients initiated treatment within one day, compared to 70 % of culture-positive but Xpert-negative and 13 % of culture- and Xpert-negative but cytology-positive patients. Xpert is accurate and effective and could be endorsed as the initial diagnos…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, only 4 studies exclusively focused on the diagnosis of TL, all of them performed in high incidence areas for tuberculosis, showing a sensitivity of 93% to 100%.22–25”
From Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country (2015) · cites this paper as [22]
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641 · cited 1×
“Approximately 30 years ago, the human immunodeficiency virus (HIV) was initially named the “lymphadenopathyassociated virus” [1, 2] and “chronic lymphadenopathy syndrome” was used for acquired immunodeficiency syndrome (AIDS), highlighting the importance of HIV-associated lymphadenopathy [3].”
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 1×
“December 2010, the World Health Organization (WHO) endorsed the Xpert MTB/RIF (Xpert) assay (Cepheid, Sunnyvale, CA, USA) as the initial diagnostic for HIVassociated and drug-resistant pulmonary tuberculosis [7, 8].”
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013 · cited 1×
“December 2010, the World Health Organization (WHO) endorsed the Xpert MTB/RIF (Xpert) assay (Cepheid, Sunnyvale, CA, USA) as the initial diagnostic for HIVassociated and drug-resistant pulmonary tuberculosis [7, 8].”
Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?
Vadwai, V., Boehme, C., Nabeta, P., Shetty, A., Alland, D., & Rodrigues, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-10 · Cited by 357 · cited 2×
“While several studies have assessed the value of Xpert for extrapulmonary samples, only eight included FNA samples [12–19], of which three provided diagnostic performance estimates for FNA, with sensitivities ranging from 84.”
The Acquired Immunodeficiency Syndrome: An Update
FAUCI, A. S., MASUR, H., GELMANN, E. P., MARKHAM, P. D., HAHN, B. H., & LANE, H. C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-800 · Cited by 338
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322 · cited 2×
“While several studies have assessed the value of Xpert for extrapulmonary samples, only eight included FNA samples [12–19], of which three provided diagnostic performance estimates for FNA, with sensitivities ranging from 84.”
Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Deng, S., & Chen, M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.012 · Cited by 267 · cited 1×
“1 % of Xpert for extrapulmonary tuberculosis, but few studies have reported accuracy by specimen type and most were performed in low tuberculosis and HIV burden settings [9].”
Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179 · cited 1×
“While several studies have assessed the value of Xpert for extrapulmonary samples, only eight included FNA samples [12–19], of which three provided diagnostic performance estimates for FNA, with sensitivities ranging from 84.”
Research works printed but not linked: 1
- Scott L, Gous N, Perovic O, Stevens W (2011) Dried culture spots for Xpert MTB/RIF external quality assessment. Paper presented at the 6th International AIDS Society Conference, Rome, Italy, July 2011
Cited by
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Maynard-Smith, L., Larke, N., Peters, J. A., & Lawn, S. D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0709-7 · Cited by 218
“text review, 55 papers were subsequently excluded, and 31 papers containing data on the diagnostic accuracy of Xpert MTB/RIF for TB when testing non-respiratory samples were reviewed in detail [12-38].”
BackgroundKohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Scott, L. E., Beylis, N., Nicol, M. P., Nkuna, G., Molapo, S., Berrie, L., Duse, A. G., & Stevens, W. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03553-13 · Cited by 118
“Three studies from the region on the performance of Xpert on EPTB specimens have to date focused only on pleural TB (8), TB lymphadenitis (18), and HIV-associated lymph node TB (LNTB) (19) in specific settings.”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Van Rie, A., Page-Shipp, L., Mellet, K., Scott, L., Mkhwnazi, M., Jong, E., Omar, T., Beylis, N., Stevens, W., Sanne, I., & Menezes, C. N.
- Affiliations
- University of the Witwatersrand (ZA)
- Right to Care (ZA)
- National Health Laboratory Service (ZA)
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2013-05-10
- Volume
- 32
- Issue
- 11
- Pages
- 1409-1415
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- OpenAlex
- W2162803569
- Cited by
- 24
- References
- 20
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 6 · 2013: 2
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- United States Agency for International Development
- U.S. President’s Emergency Plan for AIDS Relief
- U.S. Public Health Service (U2RTW007370)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- Xpert MTB/RIF, extrapulmonary tuberculosis, diagnostic accuracy, fine-needle aspiration, liquid culture, cytology, CD4 count, tuberculosis treatment initiation, molecular tuberculosis diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Bacteriological Techniques, Female, Humans, Male, Middle Aged, Sensitivity and Specificity, Time Factors, Tuberculosis, Lymph Node, HIV Infections, Molecular Diagnostic Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis. https://app.cochat.ai/papers/10.1007/s10096-013-1890-0
- The paper
- Van Rie, A., Page-Shipp, L., Mellet, K., Scott, L., Mkhwnazi, M., Jong, E., Omar, T., Beylis, N., Stevens, W., Sanne, I., & Menezes, C. N. (2013). Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-013-1890-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.